P

Protagonist Therapeutics
D

PTGX

56.290
USD
0.04
(0.07%)
مفتوح الان
حجم التداول
1,012
الربح لكل سهم
-2
العائد الربحي
-
P/E
77
حجم السوق
3,501,875,090
أصول ذات صلة
B
BEAM
-0.355
(-2.17%)
15.990 USD
C
CRSP
-0.820
(-1.51%)
53.350 USD
E
EDIT
0.04000
(1.52%)
2.68000 USD
GILD
GILD
1.900
(1.61%)
119.900 USD
MRNA
MRNA
-0.360
(-1.29%)
27.570 USD
N
NTLA
-0.36000
(-3.50%)
9.94000 USD
VRTX
VRTX
9.21
(2.36%)
400.39 USD
المزيد
الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.